Hedge Fund - Vivo Capital
Eiger Biopharmaceuticals Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2022 - Q2 (2022-06-30) | $0 | 0% | 0 | $ |
| 2 | 2022 - Q1 (2022-03-31) | $35,000 | 0% | 4,166 | $ |
| 3 | 2021 - Q4 (2021-12-31) | $22,000 | 0% | 4,166 | $ |
| 4 | 2021 - Q3 (2021-09-30) | $3,137,000 | 0.14% | 469,588 | $ |
| 5 | 2021 - Q2 (2021-06-30) | $15,262,000 | 0.66% | 1,791,257 | $ |
| 6 | 2021 - Q1 (2021-03-31) | $15,853,000 | 0.55% | 1,791,257 | $ |
| 7 | 2020 - Q4 (2020-12-31) | $22,015,000 | 0.98% | 1,791,257 | $ |
| 8 | 2020 - Q3 (2020-09-30) | $14,581,000 | 0.84% | 1,791,257 | $ |
| 9 | 2020 - Q2 (2020-06-30) | $17,196,000 | 1.23% | 1,791,257 | $ |
| 10 | 2020 - Q1 (2020-03-31) | $12,181,000 | 1.1% | 1,791,257 | $ |
| 11 | 2019 - Q3 (2019-09-30) | $0 | 0% | 0 | $ |
| 12 | 2019 - Q2 (2019-06-30) | $18,987,000 | 1.77% | 1,791,257 | $ |
| 13 | 2019 - Q1 (2019-03-31) | $25,042,000 | 2.49% | 1,791,257 | $ |
| 14 | 2018 - Q4 (2018-12-31) | $18,199,000 | 2.32% | 1,791,257 | $ |
| 15 | 2018 - Q3 (2018-09-30) | $21,495,000 | 2.16% | 1,791,257 | $ |
| 16 | 2018 - Q2 (2018-06-30) | $21,853,000 | 2.81% | 1,791,257 | $ |
| 17 | 2018 - Q1 (2018-03-31) | $17,644,000 | 2.49% | 1,791,257 | $ |
| 18 | 2017 - Q4 (2017-12-31) | $24,988,000 | 5.35% | 1,791,257 | $ |
| 19 | 2017 - Q3 (2017-09-30) | $19,658,000 | 3.97% | 1,787,091 | $ |
| 20 | 2017 - Q2 (2017-06-30) | $14,118,000 | 3.55% | 1,787,091 | $ |
| 21 | 2017 - Q1 (2017-03-31) | $20,462,000 | 6.01% | 1,787,091 | $ |
| 22 | 2016 - Q4 (2016-12-31) | $20,820,000 | 6.86% | 1,787,091 | $ |
| 23 | 2016 - Q3 (2016-09-30) | $23,929,000 | 7.45% | 1,787,091 | $ |
| 24 | 2016 - Q2 (2016-06-30) | $31,704,000 | 8.65% | 1,599,591 | $ |
| 25 | 2016 - Q1 (2016-03-31) | $26,825,000 | 6.72% | 1,599,592 | $ |
The displayed share prices are average quarterly stock market prices.